# Spark Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spark-biomedical

- Industry: Medical Devices & Equipment
- Headquarters: Dallas, US
- Website: www.sparkbiomedical.com
- Total disclosed funding: $31M
- Latest round: Series A (Apr 29, 2025)
- Investors on record: 2

## About

Based in Texas, US, and founded in 2018 by Daniel Powell, Spark Biomedical, Inc. operates as the developer of a non-invasive wearable neurostimulation tool intended to ease the symptoms of opioid withdrawal. In?September 2025,?Spark Biomedical, Inc.?received?an undisclosed amount of?grant?funding?from new investor Wellcome Leap. Spark Biomedical develops and offers drug-free wearable devices that are transcutaneous nerve field stimulators providing significant relief for patients suffering from opioid withdrawal. Intended for use alongside standard symptomatic medications and therapies under clinical supervision, the Sparrow Ascent enables patients to avoid experiencing withdrawal before treatment and eliminates concerns about misuse, overdose, or systemic side effects.

## Funding rounds

- Series A, Apr 29, 2025, $15M — Wave Ventures, Pathway to Cures
- Series A, Mar 7, 2023, $16M — Wave Ventures

## Investors

- Wave Ventures — Series A
- Pathway to Cures (https://capitalatlas.ai/funds/pathway-to-cures) — Series A